Kardigan
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $303M
Investors
- 6
About Kardigan
Established in 2023, and based in California, US, Kardigan, Inc. engages in providing cardiovascular treatments. Kardigan is developing a portfolio of advanced cardiovascular therapeutics to modify the underlying causes of cardiovascular diseases. The offerings consist of late-stage clinical candidates that target critical disease drivers, facilitating effective patient segmentation and streamlined clinical trials. By utilising a proprietary set of cardiac-specific tools, Kardigan validates markers for safety, efficacy, and patient selection in human studies. The company leverages real-world clinical data to enhance its understanding of cardiovascular diseases and the potential impact of its therapies. The products cater to healthcare providers, including hospitals and specialty clinics.
Who invested in Kardigan
6 investors across 2 rounds
See all investors in Kardigan
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kardigan
Who invested in Kardigan?
Kardigan has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kardigan raised?
Kardigan has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kardigan last raise money?
Kardigan's most recent round on record is a Series B, in Oct 2025.
What does Kardigan do?
Established in 2023, and based in California, US, Kardigan, Inc.
Where is Kardigan headquartered?
Kardigan is headquartered in South San Francisco, US.
Which VCs invest in companies like Kardigan?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kardigan's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Kardigan? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.